Skip to content
Recall Observatory FDA recall evidence

Drug product

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64

D-0161-2024

January 26, 2022

Class II

Product summary

Firm
CARDINAL HEALTHCARE
Event
Event 89450
Status
Terminated
Classification
Class II
Quantity
2 cartons
Official record key
drug-enforcement:D-0161-2024

Official wording

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Code information: Batch 21C56

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations